Skip to content

Check of Optical Features and Accuracy of the Zeiss ZO Lens After Selection and Calculation With OKULIX

Check of Optical Features and Accuracy of the Zeiss ZO Lens of the Company Carl Zeiss Meditec After Selection and Calculation With OKULIX

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00842959
Acronym
ZO Okulix
Enrollment
120
Registered
2009-02-12
Start date
2009-02-28
Completion date
2011-01-31
Last updated
2011-06-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract

Keywords

Improvement of adjustment accuracy of intraocular lenses and imaging quality

Brief summary

It is planned to implant the intraocular lenses XL Stabi ZO and Invent ZO into the eyes of patients for whom a cataract operation is medically indicated. The lenses are marketed and CE certified. Their implantation is clinical routine. In the trial the accuracy of prediction of target refraction and the difference between calculated and measured contrast vision will be examined for both lens types.

Interventions

DEVICEInvent ZO

monofocal aspheric IOL for implantation into capsular bag

DEVICEXL Stabi ZO

monofocal aspheric IOL for implantation into capsular bag

Sponsors

Carl Zeiss Meditec AG
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Indication for cataract operation * Written informed consent of patient after information

Exclusion criteria

* Immobility * Limited capacity of understanding * Diseases that hamper a follow-up examination * Astigmatism \>2.0 D * Patients with ocular diseases who may be expected to show a vision of less than 0.63 (decimal) two months after cataract surgery with implantation of intraocular lens * Complications during surgery, especially complications with positioning of the intraocular lens and with capsulorhexis

Design outcomes

Primary

MeasureTime frame
Difference between calculated and measured contrast vision.postop.
Accuracy of prediction of target refractionpostop.

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026